Ms Kate Bennett

Profile

I am a Senior Clinical Trials Statistician within the Centre for Evaluation and Methods for Barts Clinical Trials Unit, Queen Mary University of London. My primary expertise is in statistics, but I regard myself as a trialist, with extensive knowledge and experience in the design, delivery and dissemination of clinical trials and clinical research studies.  I have a mixed professional background, which includes work in social care and supported employment settings where disadvantaged groups facing additional challenges in accessing and benefitting from research outputs. These experiences push me to strive for better health and social outcomes certainly, but also for better and more equitable research, seeking to empower people to intervene in their own path to better health. I work on studies in a wide range of disease areas, including mental health, cancer, health service delivery and digital health tools. In addition to my primary role with Barts CTU, I support several trial oversight committees (data monitoring, trial steering) as part of collegiate academic work. I spent several years working with the Research Design Service (now the Research Support Service), using my skills to support research teams to develop research proposals for competitive funding applications.

For me, an important part of health research is seeing how it makes a significant difference to individuals, not just statistically in an academic paper. For this reason, and because I like to get up from my desk sometimes, I work as a qualified PT-PT (Part-Time Personal Trainer), working individually with clients to help them rediscover their strength and mobility and with the aim of increasing their healthy lifespan.

Research

Research Interests:

My main research interests lie in common non-communicable diseases such as metabolic disorders and obesity, and those living with multimorbidity.  I am particularly interested in how the way we live is making us sick, and the role of exercise as medicine, especially its contribution to healthy ageing and disease prevention.  

Publications

Please click through to see a complete list of Kates's publications.

Featured publications

Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Freemantle N. (2024). Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet, S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4.

Taylor C, Ollis L, Lyon RM, Williams J, Skene SS, Bennett K, Glover M, Munro S, Mortimer C; SEE-IT Trial Group. (2024). The SEE-IT Trial: emergency medical services Streaming Enabled Evaluation In Trauma: a feasibility randomised controlled trial. Scand J Trauma Resusc Emerg Med, 26;32(1):7. doi: 10.1186/s13049-024-01179-0. 

Barley EA, Bovell M, Bennett K, Lee JT, Lee-Baggley D, Skene SS, Tai MZ, Brooks S, Scholtz S. (2023). Addressing a critical need: A randomised controlled feasibility trial of acceptance and commitment therapy for bariatric surgery patients at 15-18 months post-surgery. PLoS One,  25;18(4):e0282849. doi: 10.1371/journal.pone.0282849

Day AC, Burr JM, Bennett K, Hunter R, Bunce C, Doré CJ, et al. (2021). Femtosecond laser-assisted cataract surgery compared with phacoemulsification: the FACT non-inferiority RCT. Health Technol Assess, 25(6). doi.org/10.3310/hta25060

Gilson R, Nugent D, Bennett K, Doré CJ, Murray ML, Copas AJ. (2020). Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Health Tehcnol Assess, 24(47): 1-86. doi: 10.3310/hta24470